← Leaderboards
Ganesha Rai Bantukallu
National Center For Advancing Translational Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Center For Advancing Translational Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Screening”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,487,925
- David Heimbrook · Leidos Biomedical Research, Inc.$277,323,479
- Richard A Gibbs · Baylor College Of Medicine$249,395,936
- David R. Weir · University Of Michigan At Ann Arbor$236,797,614
- Peter B. Gilbert · Fred Hutchinson Cancer Center$153,633,436
- Ralph Parchment · Leidos Biomedical Research, Inc.$135,017,102
Research focus
ScreeningPharmaceutical PreparationsSmall MoleculeNational Center For Advancing Translational SciencesHigh Throughput ScreeningCellsLibrariesSignal TransductionPharmaceutical ChemistryInhibitorCollectionGamma-Aminobutyric AcidTretinoinLuciferasesReportingAldehydesAldehyde DehydrogenasesEnzymesStructure-Activity RelationshipValidationIn SilicoCytotoxicityPharmacologicDesign
Grant awards (28)
Selective Inhibitors of ALDH1A1$418,442
ZIA · FY2025 · TR · contact PI
Identification of isoform-selective ALDH inhibitors$139,481
ZIA · FY2025 · TR · contact PI
Identification of GIRK2 channel modulators$139,481
ZIA · FY2025 · TR · contact PI
Selective Inhibitors of ALDH1A1$491,448
ZIA · FY2024 · TR · contact PI
Screening for small molecule modulators of SCFbTrCP ubiquitin ligase complex$327,632
ZIA · FY2024 · TR · contact PI
Screening for B. burgdorferi borreliacidal/borreliastatic compounds$327,632
ZIA · FY2024 · TR · contact PI
qHTS to Identify Inhibitors of Rabies Virus$245,724
ZIA · FY2024 · TR · contact PI
Identification of isoform-selective ALDH inhibitors$163,816
ZIA · FY2024 · TR · contact PI
Selective Inhibitors of ALDH1A1$310,142
ZIA · FY2023 · TR · contact PI
qHTS to Identify Inhibitors of Rabies Virus$240,788
ZIA · FY2023 · TR · contact PI
Screening for B. burgdorferi borreliacidal/borreliastatic compounds$240,788
ZIA · FY2023 · TR · contact PI
Screening for small molecule modulators of SCFbTrCP ubiquitin ligase complex$125,849
ZIA · FY2023 · TR · contact PI
Identification of isoform-selective ALDH inhibitors$125,849
ZIA · FY2023 · TR · contact PI
Identification of Novel antimalarial drugs targeting asexual blood stage of P. Vivax$425,400
ZIA · FY2022 · TR · contact PI
Identification of small molecule ER modulators for Wolfram syndrome$259,560
ZIA · FY2022 · TR · contact PI
Screening for B. burgdorferi borreliacidal/borreliastatic compounds$259,560
ZIA · FY2022 · TR · contact PI
qHTS to Identify Inhibitors of Rabies Virus$259,560
ZIA · FY2022 · TR · contact PI
Screening for small molecule modulators of SCFbTrCP ubiquitin ligase complex$146,225
ZIA · FY2022 · TR · contact PI
Identification of isoform-selective ALDH inhibitors$146,225
ZIA · FY2022 · TR · contact PI
Identification of Novel antimalarial drugs targeting asexual blood stage of P. Vivax$350,724
ZIA · FY2021 · TR · contact PI
Screening for B. burgdorferi borreliacidal/borreliastatic compounds$201,957
ZIA · FY2021 · TR · contact PI
Implications of 12-Lipoxygenase and NOX-1 in beta-Cell dysfunction, a potential target for Diabetes$201,957
ZIA · FY2021 · TR · contact PI
Identification of small molecule ER modulators for Wolfram syndrome$201,957
ZIA · FY2021 · TR · contact PI
Identification of Ikaros oncoprotein destabilizers$201,957
ZIA · FY2021 · TR · contact PI
qHTS to Identify Inhibitors of Rabies Virus$201,957
ZIA · FY2021 · TR · contact PI
Identification of isoform-selective ALDH inhibitors$121,256
ZIA · FY2021 · TR · contact PI
Identification of small molecule inhibitors of DNA Methylation$186,552
ZIA · FY2020 · TR · contact PI
Identification of isoform-selective ALDH inhibitors$112,360
ZIA · FY2020 · TR · contact PI